MedTrace Logo

Samsung Medical Center-Lymphoma Cohort Study

NCT00822731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 953

Last updated 2012-05-23

No results posted yet for this study

Summary

The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.

Conditions

Interventions

DRUG

Chemotherapy with or without radiotherapy

Treatment regimen will be determined by the sub-type of lymphoma

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Seok Jin Kim, MD, PhD · Samsung Medical Center

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822731 on ClinicalTrials.gov